O

OrbiMed Portfolio holdings

AUM $3.98B
This Quarter Return
-2.08%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$10.7B
AUM Growth
+$10.7B
Cap. Flow
+$450M
Cap. Flow %
4.22%
Top 10 Hldgs %
33.33%
Holding
184
New
34
Increased
39
Reduced
24
Closed
28

Top Buys

1
EWTX icon
Edgewise Therapeutics
EWTX
$453M
2
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$121M
3
HAE icon
Haemonetics
HAE
$94.6M
4
TERN icon
Terns Pharmaceuticals
TERN
$83.4M
5
IMA
ImageneBio, Inc. Common Stock
IMA
$82.9M

Top Sells

1
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
$319M
2
PRLD icon
Prelude Therapeutics
PRLD
$241M
3
PFE icon
Pfizer
PFE
$133M
4
BIIB icon
Biogen
BIIB
$125M
5
CNC icon
Centene
CNC
$120M

Sector Composition

1 Healthcare 95.15%
2 Technology 0.12%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
QURE icon
76
uniQure
QURE
$954M
$32.6M 0.31%
969,079
– –
ALPN
77
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$32.6M 0.3%
3,070,955
– –
SCPH icon
78
scPharmaceuticals
SCPH
$296M
$31.9M 0.3%
4,797,148
– –
SYRE icon
79
Spyre Therapeutics
SYRE
$1.02B
$31.8M 0.3%
4,015,524
– –
PAND
80
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$31.7M 0.3%
528,229
-952,711
-64% -$57.2M
MRSN icon
81
Mersana Therapeutics
MRSN
$34.8M
$30.6M 0.29%
1,892,500
+1,119,152
+145% +$18.1M
NMTR
82
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
$30.1M 0.28%
25,716,755
– –
NVAX icon
83
Novavax
NVAX
$1.2B
$28.3M 0.26%
+155,833
New +$28.3M
NXTC icon
84
NextCure
NXTC
$13.3M
$27.1M 0.25%
2,711,013
– –
ACHL
85
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
$26.2M 0.25%
+1,584,845
New +$26.2M
SRRA
86
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$25.5M 0.24%
1,477,320
– –
GLTO icon
87
Galecto
GLTO
$3.93M
$24.9M 0.23%
4,090,937
– –
CRVS icon
88
Corvus Pharmaceuticals
CRVS
$419M
$24.8M 0.23%
8,053,298
+1,285,714
+19% +$3.96M
CALC icon
89
CalciMedica
CALC
$45M
$23.1M 0.22%
4,163,347
-312,500
-7% -$1.73M
ELVN icon
90
Enliven Therapeutics
ELVN
$1.24B
$23M 0.21%
2,719,902
– –
BIIB icon
91
Biogen
BIIB
$20.8B
$22.9M 0.21%
82,000
-447,400
-85% -$125M
AMGN icon
92
Amgen
AMGN
$153B
$22.8M 0.21%
91,500
– –
VRCA icon
93
Verrica Pharmaceuticals
VRCA
$49.4M
$22.4M 0.21%
1,479,733
– –
CTIC
94
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$21.9M 0.2%
7,520,600
-2,000,000
-21% -$5.82M
OLMA icon
95
Olema Pharmaceuticals
OLMA
$432M
$21.8M 0.2%
656,126
+5,134
+0.8% +$170K
LAB icon
96
Standard BioTools
LAB
$493M
$20.8M 0.19%
4,599,571
+707,225
+18% +$3.2M
FLXN
97
DELISTED
Flexion Therapeutics, Inc.
FLXN
$20.7M 0.19%
2,308,083
– –
KDNY
98
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$19.4M 0.18%
1,250,001
– –
JNCE
99
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$18.7M 0.18%
+1,823,600
New +$18.7M
GILD icon
100
Gilead Sciences
GILD
$140B
$18.6M 0.17%
287,600
+95,400
+50% +$6.17M
2 3
4
5 6